FDA Inspection 1099381 — Padagis Israel Pharmaceuticals Ltd.
The FDA completed an inspection of Padagis Israel Pharmaceuticals Ltd. on Jun 13, 2019 in Yerucham. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Yerucham (Israel)
Additional details
Bioanalytical BA/BE